Erratum: SRT1720 improves survival and healthspan of obese mice (Scientific Reports (2011) 1 (70) DOI: 10.1038/srep00070);SRT1720 improves survival and healthspan of obese mice

Scientific Reports

Volumn 1, Issue , 2011, Pages

  Minor, Robin K ^a   Baur, Joseph A ^b   Gomes, Ana P ^c   Ward, Theresa M ^a   Csiszar, Anna ^d   Mercken, Evi M ^a   Abdelmohsen, Kotb ^a   Shin, Yu Kyong ^a   Canto, Carles ^e   Scheibye Knudsen, Morten ^a   Krawczyk, Melissa ^a   Irusta, Pablo M ^a,f   Martín Montalvo, Alejandro ^a   Hubbard, Basil P ^c   Zhang, Yongqing ^a   Lehrmann, Elin ^a   White, Alexa A ^a   Price, Nathan L ^c   Swindell, William R ^c   Pearson, Kevin J ^a,g   Becker, Kevin G ^a   Bohr, Vilhelm A ^a   Gorospe, Myriam ^a   Egan, Josephine M ^a   Talan, Mark I ^a   Auwerx, Johan ^e   Westphal, Christoph H ^h   Ellis, James L ^h   Ungvari, Zoltan ^d   Vlasuk, George P ^h   Elliott, Peter J ^h   Sinclair, David A ^c   De Cabo, Rafael ^a   more..

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e EPFL   (Switzerland)

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF KENTUCKY   (United States)

^h GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUSED HETEROCYCLIC RINGS; GLUCOSE; SRT1720;

ANIMAL; APOPTOSIS; ARTICLE; BODY COMPOSITION; C57BL MOUSE; DRUG EFFECT; FAT INTAKE; GENE EXPRESSION; HOMEOSTASIS; LIVER; LONGEVITY; MALE; METABOLISM; MOUSE; OBESITY; PANCREAS; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; APOPTOSIS; BODY COMPOSITION; DIETARY FATS; GENE EXPRESSION; GLUCOSE; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HOMEOSTASIS; LIVER; LONGEVITY; MALE; MICE; MICE, INBRED C57BL; OBESITY; PANCREAS;

EID: 84859909860     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01131     Document Type: Erratum

References (48)

1. Schrager, M. A. et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J. Appl. Physiol. 102, 919-925 (2007). (Pubitemid 46377013)
2. Cesari, M. et al. Sarcopenia, obesity, and inflammation-results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am. J. Clin. Nutr. 82, 428-434 (2005).
3. Tissenbaum, H. A. & Guarente, L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227-230 (2001). (Pubitemid 32216597)
4. Howitz, K. T. et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196 (2003). (Pubitemid 37150899)
5. Lavu, S., Boss, O., Elliott, P. J. & Lambert, P. D. Sirtuins-novel therapeutic targets to treat age-associated diseases. Nat. Rev. Drug Discov. 7, 841-853 (2008).
6. Knutson, M. D. & Leeuwenburgh, C. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutr. Rev. 66, 591-596 (2008).
7. Baur, J. A. et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342 (2006). (Pubitemid 44764104)
8. Banks, A. S. et al. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. 8, 333-341 (2008).
9. Pfluger, P. T., Herranz, D., Velasco-Miguel, S., Serrano, M. & Tschöp, M. H. Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. U. S. A. 105, 9793-9798 (2008). (Pubitemid 352031379)
10. Baur, J. A. & Sinclair, D. A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5, 493-506 (2006). (Pubitemid 44136961)
11. Milne, J. C. et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712-716 (2007). (Pubitemid 350207685)
12. Feige, J. N. et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 8, 347-358 (2008).
13. Yoshizaki, T. et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 298, E419-E428 (2010).
14. Pacholec, M. et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem. 285, 8340-8351 (2010).
15. Dai, H. et al. SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator. J. Biol. Chem. 285, 32695-32703 (2010).
16. Yamazaki, Y. et al. Treatmentwith SRT1720, a SIRT1 Activator, Ameliorates Fatty Liver with Reduced Expression of Lipogenic Enzymes in MSG Mice. Am. J. Physiol. Endocrinol. Metab. 297, E1179-E1186 (2009).
17. Walker, A. K. et al. Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev. 24, 1403-1417 (2010).
18. Li, Y. et al. Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. FASEB J. (2011). [Epub ahead of print]
19. Pearson, K. J. et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 8, 157-168 (2008).
20. He, W. et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J. Clin. Invest. 120, 1056-1068 (2010).
21. Smith, J. J. et al. Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo. BMC Syst. Biol. 10, 31 (2009).
22. Park, S. K. et al. Gene expression profiling of aging in multiple mouse strains: identification of aging biomarkers and impact of dietary antioxidants. Aging Cell 8, 484-495 (2009).
23. Barger, J. L., Kayo, T., Pugh, T. D., Prolla, T. A. & Weindruch, R. Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart. Exp. Gerontol. 9, 859-866 (2008).
24. Barger, J. L. et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One 3, e2264 (2008) [published erratum appears in: PLoS ONE 3 (2008)].
25. Takata, T. & Ishikawa, F. Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1-and HEY2-mediated transcriptional repression. Biochem. Biophys. Res. Commun. 301, 250-257 (2003). (Pubitemid 36268876)
26. Brunet, A. et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015 (2004). (Pubitemid 38393275)
27. Escande, C. et al. Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. J. Clin. Invest. 120, 545-558 (2010).
28. Swindell, W. R. Gene expression profiling of long-lived dwarf mice: longevityassociated genes and relationships with diet, gender and aging. BMC Genomics 3, 353 (2007).
29. Coste, A. et al. The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1{alpha}. Proc. Natl. Acad. Sci. U. S. A. 105, 17187-17192 (2008).
30. Lagouge, M. et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127, 1109-1122 (2006). (Pubitemid 44894520)
31. Wareski, P. et al. PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons. J. Biol. Chem. 284, 21379-21385 (2009).
32. Beeson, C. C., Beeson, G. C. & Schnellmann, R. G. A high-throughput respirometric assay for mitochondrial biogenesis and toxicity. Anal. Biochem. 404, 75-81 (2010).
33. López-Lluch, G. et al. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc. Natl. Acad. Sci. U. S. A. 103, 1768-1773 (2006). (Pubitemid 43228768)
34. Lambert, A. J., Wang, B., Yardley, J., Edwards, J. & Merry, B. J. The effect of aging and caloric restriction on mitochondrial protein density and oxygen consumption. Exp. Gerontol. 39, 289-295 (2004). (Pubitemid 38264359)
35. Anderson, R. M. et al. Dynamic regulation of PGC-1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response. Aging Cell 7, 101-111 (2008).
36. Herranz, D. et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nature Communications 1, 1-8 (2010) doi:10. 1038/ncomms1001.
37. Kaeberlein, M. et al. Substrate-specific activation of sirtuins by resveratrol. J. Biol. Chem. 280, 17038-17045 (2005). (Pubitemid 41389166)
38. Borra, M. T., Smith, B. C. & Denu, J. M. Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 280, 17187-17195 (2005). (Pubitemid 41389185)
39. Beher, D. et al. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem. Biol. Drug Des. 74, 619-624 (2009).
40. Liu, Y. et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 456, 269-273 (2008).
41. Yoshizaki, T. et al. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol. Cell Biol. 29, 1363-1374 (2009).
42. Funk, J. A., Odejinmi, S. & Schnellmann, R. G. SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells. J. Pharmacol. Exp. Ther. 333, 593-601 (2010).
43. Rolo, A. P., Palmeira, C. M. & Wallace, K. B. Mitochondrially mediated synergistic cell killing by bile acids. Biochim. Biophys. Acta. 1637, 127-132 (2003). (Pubitemid 36071606)
44. Cheng, H. L. et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 100, 10794-10799 (2003).
45. Gazotti, P., Malmstrom, K. & Brdiczka, D. Membrane biochemistry: A laboratory manual on transport and bioenergetics. In: E. Carafoli, E., Semenza, G. (Eds), Springer-Verlag, New York, pp 6-69 (1979).
46. Rolo, A. P., Oliveira, P. J., Moreno, A. J. & Palmeira, C. M. Bile acids affect liver mitochondrial bioenergetics: possible relevance for cholestasis therapy. Toxicol. Sci. 57, 177-185 (2000).
47. Gornall, A. G., Bardawill, C. J. & David, M. M. Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 177, 751-766 (1949).
48. Estabrook, R. W. Mitochondrial respiratory control and the polarographic measurements of ADP/O ratios. Methods Enzymol. 10, 41-47 (1967).